Trimetazidine as adjunctive therapy to primary PTCA for acute myocardial infarction

Revista Portuguesa de Cardiologia

Volumn 19, Issue SUPPL. 5, 2000, Pages 31-34

  Beygui, F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Myocardial infarction; Primary PTCA; Trimetazidine

Indexed keywords

ANTIANGINA PECTORIS AGENT; PLACEBO; TRIMETAZIDINE;

ACUTE HEART INFARCTION; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; THROMBOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0034522476     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
2. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
3. Limitation of myocardial infarct size after primary angioplasty: Is a higher patency the only mechanism?
4. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA
5. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome
6. Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarction
7. The "no-reflow" phenomenon after temporary coronary occlusion in the dog
8. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary, angioplasty in patients with acute anterior wall myocardial infarction
9. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up
10. Predictors of outcome of reperfusion therapy
11. Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: Contribution of Holter electrocardiographic ambulatory monitoring
12. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions
13. Myocardial cytoprotection during percutaneous transluminal coronary angioplasty
14. Free radicals, reperfusion and myocardial infarction therapy: European Myocardial Infarction Project-free radicals pilot study
15. Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis
16. Protective effects of trimetazidine on hypoxic cardiac myocytes from the rat
17. Limitation of infarct size by trimetazidine in the rabbit
18. Inhibitory effect of trimetazidine on thrombin-induced aggregation and calcium entry into human platelets
19. Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits
20. A randomized double-blinded trial of trimetazidine as adjunctive therapy to primary PTCA for acute myocardial infarction: Evidence for improved myocardial reperfusion from ST-segment analysis